Syros Pharmaceuticals Inc. (SYRS) Stock: Thought Concerns
H.C. Wainwright raised the price target for the Syros Pharmaceuticals Inc. (NASDAQ:SYRS) stock from “a Neutral” to “a Buy”. The rating was released on November 04, 2020, according to finviz. The stock was resumed by JMP Securities, who disclosed in a research note on March 08, 2019, to Mkt Outperform and set the price objective […]
